Public Pharma: still a missing debate in mainstream academia
World

Public Pharma: still a missing debate in mainstream academia

Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution

Alan Rossi Silva
February 17, 2025
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
World

Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug

The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma

Alan Rossi Silva
September 10, 2024
29 years without Jonas Salk: against the normalization of the absurd
World

29 years without Jonas Salk: against the normalization of the absurd

Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry

Alan Rossi Silva and Joost Smiers
June 21, 2024
Access to health summit
World

Access to medicines summit urges for more decisive action against Big Pharma domination

Activists and academics discussed future of the access to medicines movement at the Global Summit on Intellectual Property and Access to Medicines in Istanbul at the end of July

Lauren Paremoer and Alan Rossi Silva
August 19, 2022